We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$622B
AUM Growth
+$11.2B
Cap. Flow
-$16.1B
Cap. Flow %
-2.59%
Top 10 Hldgs %
26.59%
Holding
3,066
New
113
Increased
1,569
Reduced
1,081
Closed
107

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.6B
2
VZ icon
Verizon
VZ
+$1.3B
3
USB icon
US Bancorp
USB
+$1.26B
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26B
5
LRCX icon
Lam Research
LRCX
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.64%
3 Financials 12.72%
4 Consumer Discretionary 10.95%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUFG icon
1276
Mitsubishi UFJ Financial
MUFG
$261B
$3.28M ﹤0.01%
491,355
+33,978
+7% +$176K
MCRB icon
1277
Seres Therapeutics
MCRB
$45.5M
$3.26M ﹤0.01%
29,127
+477
+2% +$64K
STAG icon
1278
STAG Industrial
STAG
$7.12B
$3.26M ﹤0.01%
100,762
+7,912
+9% +$248K
COHR icon
1279
Coherent
COHR
$65.2B
$3.25M ﹤0.01%
92,663
+13,803
+18% +$480K
OFG icon
1280
OFG Bancorp
OFG
$2.26B
$3.25M ﹤0.01%
117,997
+57,227
+94% +$1.57M
GTLS
1281
DELISTED
Chart Industries
GTLS
$3.23M ﹤0.01%
28,055
+3,630
+15% +$583K
ERIE icon
1282
Erie Indemnity
ERIE
$13.3B
$3.23M ﹤0.01%
12,975
+1,338
+11% +$344K
NRDS icon
1283
NerdWallet
NRDS
$629M
$3.23M ﹤0.01%
335,892
-192,116
-36% -$2.16M
ALG icon
1284
Alamo Group
ALG
$2.04B
$3.22M ﹤0.01%
22,722
+3,262
+17% +$472K
DOX icon
1285
Amdocs
DOX
$6.16B
$3.21M ﹤0.01%
35,334
+1,489
+4% +$127K
NGG icon
1286
National Grid
NGG
$81.3B
$3.21M ﹤0.01%
56,446
+2,900
+5% +$155K
MTZ icon
1287
MasTec
MTZ
$23.5B
$3.21M ﹤0.01%
37,589
+416
+1% +$34.1K
NVT icon
1288
nVent Electric
NVT
$28.1B
$3.2M ﹤0.01%
83,232
-2,882
-3% -$106K
AMG icon
1289
Affiliated Managers Group
AMG
$9.69B
$3.19M ﹤0.01%
20,115
+43
+0.2% +$6.08K
COLD icon
1290
Americold
COLD
$4.27B
$3.18M ﹤0.01%
112,275
+1,967
+2% +$52.9K
ATR icon
1291
AptarGroup
ATR
$8.34B
$3.17M ﹤0.01%
28,780
-1,796
-6% -$184K
VVV icon
1292
Valvoline
VVV
$4.32B
$3.17M ﹤0.01%
96,951
-5,720
-6% -$173K
DINO icon
1293
HF Sinclair
DINO
$16.5B
$3.16M ﹤0.01%
60,925
-1,304
-2% -$75.1K
IWB icon
1294
iShares Russell 1000 ETF
IWB
$50.5B
$3.15M ﹤0.01%
14,956
+28
+0.2% +$5.93K
WHWK
1295
Whitehawk Therapeutics
WHWK
$255M
$3.15M ﹤0.01%
245,243
-6,036
-2% -$78.8K
KBR icon
1296
KBR
KBR
$4.84B
$3.14M ﹤0.01%
59,531
-517
-0.9% -$25.7K
SAIC icon
1297
Saic
SAIC
$5.33B
$3.14M ﹤0.01%
28,326
+674
+2% +$71K
QGEN icon
1298
Qiagen
QGEN
$8.92B
$3.13M ﹤0.01%
59,178
+4,307
+8% +$212K
MPT
1299
Medical Properties Trust
MPT
$2.5B
$3.12M ﹤0.01%
279,875
-7,513
-3% -$87.3K
MGEE icon
1300
MGE Energy Inc
MGEE
$3.08B
$3.12M ﹤0.01%
44,248
+11,279
+34% +$775K

Similar funds

T. Rowe Price Associates's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
  • T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
  • T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
  • T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
  • T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
  • T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
  • T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.